About Talphera
Talphera is a Healthcare company based in San Mateo (United States). Innovative therapies are developed by Talphera for medically supervised settings. It operates on a HealthTech and Licensing Model model. Talphera has completed 1 acquisition, including Lowell Therapeutics. Talphera offers products and services including Niyadâ„¢, LTX-608â„¢, Fedsyraâ„¢, and PFS-02. Its focus areas include Biotechnology, Medical Devices, Pharmaceuticals and Specialty Pharmaceuticals.
Company details
Innovative therapies and medical devices are developed and commercialized by Talphera for use in medically supervised settings. Focus is placed on improving patient outcomes through advanced tools for healthcare providers. Sectors include renal replacement therapy and acute care settings. Solutions such as Niyad, a regional anticoagulant for dialysis circuits, and pre-filled syringes like Fedsyra and PFS-02 are offered to enhance safety and efficiency. Additionally, LTX-608 is explored for anti-inflammatory and antiviral applications across various conditions.
- Headquarters San Mateo, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website talphera.com
- Investments & Acquisitions
Products & Services of Talphera
Talphera offers a comprehensive portfolio of products and services, including Niyad™, LTX-608™, Fedsyra™, and PFS-02.
Regional anticoagulant developed for extracorporeal circuit in dialysis.
Investigated for anti-inflammatory and antiviral therapeutic applications.
Pre-filled syringe developed for hypotension treatment during anesthesia.
Pre-filled syringe created for hypotension and related conditions.
People of Talphera
4 people are tracked at Talphera (4 in leadership).
| Name | Role | Group |
|---|---|---|
Raffi Asadorian | CFO | Leadership |
Pamela P. Palmer | Chief Medical Officer and Co-Founder | Leadership |
Badri Dasu | Chief Engineering Officer | Leadership |
Vincent J. Angotti | CEO | Leadership |
Complete people profiles for Talphera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Talphera
Talphera has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lowell Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of anticoagulant for the treatment of acute kidney diseases | ltx.life | Lowell, United States | 2018 | Nov 2021 | •••• |
Complete acquisition details for Talphera
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Web traffic of Talphera
Websites that share an audience with Talphera (acelrx.com).
Websites whose visitors overlap most with Talphera. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| supernus.com | 77% | 18.7K | #1,928,683 | View details |
Top companies in Medical Device Tech & Outsourcing
3 companies that operate in the same segment as Talphera (Medical Device Tech & Outsourcing) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Home medical and respiratory equipment and supplies are distributed. | 2005 | Phoenixville, Pennsylvania, United States | USD 4 M | USD 3.24 B | 10,500 | |
Cybersecurity solutions for medical devices are provided by MedCrypt. | 2016 | San Diego, California, United States | USD 63.75 M | |||
Laboratory and production supplies and services are provided. | 1902 | Hampton, Virginia, United States | 592 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Talphera
Talphera is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Innovative therapies and medical devices are developed and commercialized by Talphera for use in medically supervised settings. Focus is placed on improving patient outcomes through advanced tools for healthcare providers. Sectors include renal replacement therapy and acute care settings. Solutions such as Niyad, a regional anticoagulant for dialysis circuits, and pre-filled syringes like Fedsyra and PFS-02 are offered to enhance safety and efficiency. Additionally, LTX-608 is explored for anti-inflammatory and antiviral applications across various conditions.
Talphera offers Niyadâ„¢, LTX-608â„¢, Fedsyraâ„¢, and PFS-02.
Talphera has made 1 acquisition, including Lowell Therapeutics.